1 Such transformed cells
eventually succumb to crisis, a period of widespread cel
2 SV40T (BMSVTs) had an extended lifespan, but
eventually succumbed to crisis.
3 indolent, WM is incurable and most patients
eventually succumb to disease progression.
4 Treated mice
eventually succumb to disease, thus, targeting the Hedge
5 ; patients often develop drug resistance and
eventually succumb to disease.
6 ity waned with time, and the treated animals
eventually succumbed to hepatic tumor relapse or distant
7 ice initially controlled parasite growth but
eventually succumbed to infection.
8 rolonged survival, the reconstituted animals
eventually succumbed to infection.
9 ompromised mice: many micro MT and RAG1 mice
eventually succumbed to infection.
10 immunity was required because most SCID mice
eventually succumbed to local tumor recurrence even with
11 s mutants survive into early adulthood, they
eventually succumb to massive intracardiac thrombosis.
12 e (L-NMMA), a large proportion of these mice
eventually succumbed to opportunistic infections, but no
13 are usually not sustained, and most patients
eventually succumb to progressive disease, indicating th
14 rowth in systemic tissues to occur, and mice
eventually succumbed to relapsing infection.
15 Patients
eventually succumb to renal, cardio-, or cerebrovascular
16 All antimalarial drugs developed so far have
eventually succumbed to resistance.
17 variable, but approximately 20% of patients
eventually succumb to the cepacia syndrome, which is cha
18 dividuals will develop recurrent BC and will
eventually succumb to the disease.
19 tatic ccRCC, although virtually all patients
eventually succumb to the disease.
20 val, nearly all patients with advanced ccRCC
eventually succumb to the disease.
21 t to grow and differentiate in the tail, but
eventually succumb to the resorption program.
22 most women diagnosed with late-stage disease
eventually succumb to their cancer.
23 in lymphoma, yet 40% to 50% of patients will
eventually succumb to their disease, demonstrating a pre
24 after definitive locoregional treatment and
eventually succumb to their disease.
25 al malignancies, with virtually all patients
eventually succumbing to their disease.
26 ce displayed enhanced resistance though they
eventually succumbed to this infection.
27 CY plus IL-2-treated self-Ag-expressing mice
eventually succumb to tolerization, this delay results i
28 ell as acute resistance; however, these mice
eventually succumbed to toxoplasmic encephalitis, despit
29 Flt3L alone showed delayed tumor growth but
eventually succumbed to tumor progression.
30 r the host successfully rejects the tumor or
eventually succumbs to tumor outgrowth.